AR074483A1 - Composiciones, metodos y usos para inducir al crecimiento viral - Google Patents
Composiciones, metodos y usos para inducir al crecimiento viralInfo
- Publication number
- AR074483A1 AR074483A1 ARP090104712A ARP090104712A AR074483A1 AR 074483 A1 AR074483 A1 AR 074483A1 AR P090104712 A ARP090104712 A AR P090104712A AR P090104712 A ARP090104712 A AR P090104712A AR 074483 A1 AR074483 A1 AR 074483A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- methods
- induce
- growth
- viral growth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Las formas de realización de la presente informan acerca de métodos, composiciones y usos para inducir y/o acelerar el crecimiento de virus. En ciertas formas de realización, los métodos, composiciones y usos por lo general se relacionan con composiciones de copolímeros para inducir el crecimiento de virus, reducir el tiempo de retraso y/o incrementar el tamano de placa viral. En otras formas de realización, los métodos, composiciones y usos de composiciones de copolímeros pueden ser para inducir el crecimiento de flavivirus, reducir su retraso de crecimiento y/o incrementar su tamano de placa.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12026208P | 2008-12-05 | 2008-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR074483A1 true AR074483A1 (es) | 2011-01-19 |
Family
ID=42231513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090104712A AR074483A1 (es) | 2008-12-05 | 2009-12-04 | Composiciones, metodos y usos para inducir al crecimiento viral |
Country Status (20)
Country | Link |
---|---|
US (3) | US8871487B2 (es) |
EP (1) | EP2366024B1 (es) |
JP (2) | JP5728742B2 (es) |
KR (1) | KR101784951B1 (es) |
CN (2) | CN102272294B (es) |
AR (1) | AR074483A1 (es) |
AU (1) | AU2009322175B2 (es) |
BR (2) | BR122020015754B8 (es) |
CA (1) | CA2745962C (es) |
CO (1) | CO6390063A2 (es) |
CU (1) | CU20110128A7 (es) |
HR (1) | HRP20191324T1 (es) |
IL (2) | IL213389B (es) |
MX (2) | MX2011005886A (es) |
MY (1) | MY178195A (es) |
NZ (1) | NZ593415A (es) |
SG (3) | SG10201503671TA (es) |
TW (2) | TWI461536B (es) |
WO (1) | WO2010065911A1 (es) |
ZA (2) | ZA201104364B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102272294B (zh) * | 2008-12-05 | 2015-09-02 | 伊维拉根公司 | 用于诱导病毒生长的组合物、方法和用途 |
EP2746386A1 (en) * | 2012-12-21 | 2014-06-25 | Lonza Cologne GmbH | Materials and methods for cell culture |
WO2016159179A1 (ja) * | 2015-03-30 | 2016-10-06 | 味の素株式会社 | ヒト血清アルブミンを含む神経幹細胞増殖培地 |
WO2023147337A2 (en) * | 2022-01-25 | 2023-08-03 | Takeda Vaccines, Inc. | Large-scale flaviviral vaccine production and manufacture |
WO2024118740A1 (en) * | 2022-11-29 | 2024-06-06 | Takeda Vaccines, Inc. | Large-scale flaviviral vaccine production and manufacture |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5024947A (en) | 1987-07-24 | 1991-06-18 | Cetus Corporation | Serum free media for the growth on insect cells and expression of products thereby |
US5616487A (en) * | 1994-09-15 | 1997-04-01 | Aastrom Biosciences, Inc. | Stabilized retrovirus compositions |
WO1998008934A1 (en) * | 1996-08-30 | 1998-03-05 | Life Technologies, Inc. | Serum-free mammalian cell culture medium, and uses thereof |
AU4556597A (en) * | 1996-09-24 | 1998-04-17 | Bavarian Nordic Research Institute A/S | Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines |
US7732129B1 (en) * | 1998-12-01 | 2010-06-08 | Crucell Holland B.V. | Method for the production and purification of adenoviral vectors |
CA2382919C (en) | 1999-10-08 | 2008-12-09 | Gruenenthal Gmbh | Bicyclic imidazo-3-yl-amine derivatives |
ES2374131T3 (es) * | 2000-02-16 | 2012-02-14 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Flavivirus quiméricos avirulentos e inmunógenos. |
WO2003060088A2 (en) * | 2002-01-15 | 2003-07-24 | Acambis, Inc. | Viral vaccine production method |
US20050118701A1 (en) * | 2002-03-29 | 2005-06-02 | Weichang Zhou | Large scale methods of producing adenovirus and adenovirus seed stocks |
RU2237065C2 (ru) | 2002-10-03 | 2004-09-27 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Иммуногенная библиотека химерных пептидов, мимикрирующая генетическое многообразие гипервариабельного района v3 белка оболочки gp120 вируса иммунодефицита человека |
PL199642B1 (pl) * | 2002-11-15 | 2008-10-31 | Inst Immunologii I Terapii Do | Preparat bakteriofagowy o podwyższonej trwałości oraz zastosowanie blokowego kopolimeru tlenku etylenu i tlenku propylenu |
WO2008041953A2 (en) * | 2006-10-05 | 2008-04-10 | Agency For Science, Technology And Research | Dengue diagnosis and treatment |
MY180465A (en) * | 2007-04-06 | 2020-11-30 | Takeda Vaccines Inc | Methods and compositions for live attenuated viruses |
US8367370B2 (en) * | 2008-02-11 | 2013-02-05 | Wheeler Aaron R | Droplet-based cell culture and cell assays using digital microfluidics |
CN102272294B (zh) | 2008-12-05 | 2015-09-02 | 伊维拉根公司 | 用于诱导病毒生长的组合物、方法和用途 |
-
2009
- 2009-12-04 CN CN200980154016.5A patent/CN102272294B/zh active Active
- 2009-12-04 NZ NZ593415A patent/NZ593415A/en unknown
- 2009-12-04 WO PCT/US2009/066848 patent/WO2010065911A1/en active Application Filing
- 2009-12-04 BR BR122020015754A patent/BR122020015754B8/pt active IP Right Grant
- 2009-12-04 EP EP09831233.3A patent/EP2366024B1/en active Active
- 2009-12-04 AU AU2009322175A patent/AU2009322175B2/en active Active
- 2009-12-04 TW TW098141534A patent/TWI461536B/zh active
- 2009-12-04 SG SG10201503671TA patent/SG10201503671TA/en unknown
- 2009-12-04 AR ARP090104712A patent/AR074483A1/es active IP Right Grant
- 2009-12-04 SG SG2011040961A patent/SG171972A1/en unknown
- 2009-12-04 KR KR1020117015005A patent/KR101784951B1/ko active IP Right Grant
- 2009-12-04 MY MYPI2011002552A patent/MY178195A/en unknown
- 2009-12-04 MX MX2011005886A patent/MX2011005886A/es active IP Right Grant
- 2009-12-04 CA CA2745962A patent/CA2745962C/en active Active
- 2009-12-04 CN CN201510470646.0A patent/CN105219734B/zh active Active
- 2009-12-04 JP JP2011539758A patent/JP5728742B2/ja active Active
- 2009-12-04 BR BRPI0922788A patent/BRPI0922788B8/pt active IP Right Grant
- 2009-12-04 US US12/631,629 patent/US8871487B2/en active Active
- 2009-12-04 TW TW103132644A patent/TWI573874B/zh active
- 2009-12-04 SG SG10202007719TA patent/SG10202007719TA/en unknown
-
2011
- 2011-06-03 MX MX2015008630A patent/MX353602B/es unknown
- 2011-06-05 IL IL213389A patent/IL213389B/en active IP Right Grant
- 2011-06-06 CU CU20110128A patent/CU20110128A7/es unknown
- 2011-06-10 ZA ZA2011/04364A patent/ZA201104364B/en unknown
- 2011-06-17 CO CO11076067A patent/CO6390063A2/es not_active Application Discontinuation
-
2014
- 2014-09-19 US US14/491,805 patent/US9890362B2/en active Active
-
2015
- 2015-03-12 JP JP2015049625A patent/JP6174066B2/ja active Active
- 2015-05-14 IL IL238819A patent/IL238819A/en active IP Right Grant
-
2016
- 2016-01-26 ZA ZA2016/00550A patent/ZA201600550B/en unknown
-
2017
- 2017-12-28 US US15/856,770 patent/US20180251737A1/en not_active Abandoned
-
2019
- 2019-07-23 HR HRP20191324TT patent/HRP20191324T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY35131A (es) | Composiciones, métodos y usos de construcciones de virus del dengue de serotipo-4 | |
ECSP17064986A (es) | Compuestos antivirales | |
CR20110453A (es) | Combinación de un inhibidor de nucléosido polimerasa con un inhibidor de proteasa macrocíclica y su uso en el tratamiento de hepatitis c, fibrosis hepática y función hepática alterada | |
UY35266A (es) | Compuestos antivirales | |
CL2018000515A1 (es) | Virus de la enfermedad de newcastle y usos de los mismos (divisional sol. 2532-2015) | |
ECSP14013315A (es) | Inhibidores de aplicación viral | |
AR084237A1 (es) | Metodos para tratar virus de hepatitis c (hcv), composicion | |
BR112012020839A2 (pt) | vacinas para uso na profilaxe e tratamento de doença de vírus da influenza | |
CL2012000573A1 (es) | Compuestos derivados de bifenil-pirrolidinil-imidazol; composicion farmaceutica que los comprende; su uso en el tratamiento de una infeccion viral por hcv. | |
CL2008000321A1 (es) | Compuesto macrociclo en forma cristalina, inhibidor del virus de la hepatitis c (vhc); mezcla de una o mas formas cristalinas; procesos de preparacion de las formas cristalinas; y composicion farmaceutica que las comprende. | |
AR065984A1 (es) | Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c. composiciones farmaceuticas. | |
AR058215A1 (es) | Metodos y proteinas para el tratamiento profilactico y o terapeutico de los cuatro serotipos del virus de dengue y otros flavivirus | |
UY32793A (es) | Compuestos inhibidores de los virus flaviviridae, composición farmacéutica que los contiene y sus usos | |
ECSP10010002A (es) | Derivados indólicos 2,3 sustituidos y métodos de uso de los mismos | |
BR112014006324B8 (pt) | composição e seu uso para o tratamento de hcv | |
CO6541585A2 (es) | Composiciones de lipopétidos y métodos relacionados | |
ECSP099447A (es) | Derivados indólicos con anillo unido en las posiciones 4,5 y sus métodos de uso | |
CL2009002207A1 (es) | Compuestos derivados de 3-hidroxi-5-(9h-purin-9-il)tetrahidrofuran-2-il, inhibidor de la replicacion de arn viral dependiente de arn; composicion farmaceutica; uso para el tratamiento de hepatitis c. | |
ECSP066794A (es) | Nuevos compuestos como inhibidores de serina proteasa ns3 del virus de la hepatitis c | |
CO6390076A2 (es) | Inhibidores de hcv ns5a | |
CO6390077A2 (es) | Inhibidores de hacv ns5a | |
AR074483A1 (es) | Composiciones, metodos y usos para inducir al crecimiento viral | |
CL2011002548A1 (es) | Compuestos derivados de resolviina; composicion farmaceutica; uso de la composicion; kit farmaceutico; combinacion farmaceutica; uso de los compuestos en el tratamiento y/o prevencion de una condicion oftalmica. | |
SV2011003796A (es) | Derivados de indol macrociclicos utiles como inhibidores del virus de la hepatitis c | |
EA201290373A1 (ru) | Синергическая противовирусная композиция и ее применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal | ||
FG | Grant, registration |